173 related articles for article (PubMed ID: 16757558)
1. Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees.
Zhang P; Yu MY; Venable R; Alter HJ; Shih JW
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9214-9. PubMed ID: 16757558
[TBL] [Abstract][Full Text] [Related]
2. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee.
Iwarson S; Tabor E; Thomas HC; Goodall A; Waters J; Snoy P; Shih JW; Gerety RJ
J Med Virol; 1985 May; 16(1):89-96. PubMed ID: 2413167
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
[TBL] [Abstract][Full Text] [Related]
5. A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg "a" determinant.
Karthigesu VD; Allison LM; Ferguson M; Howard CR
J Med Virol; 1999 Aug; 58(4):346-52. PubMed ID: 10421400
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
[TBL] [Abstract][Full Text] [Related]
7. Virus-neutralizing antibodies to hepatitis B virus: the nature of an immunogenic epitope on the S gene peptide.
Waters J; Pignatelli M; Galpin S; Ishihara K; Thomas HC
J Gen Virol; 1986 Nov; 67 ( Pt 11)():2467-73. PubMed ID: 2431101
[TBL] [Abstract][Full Text] [Related]
8. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees.
Hong HJ; Ryu CJ; Hur H; Kim S; Oh HK; Oh MS; Park SY
Virology; 2004 Jan; 318(1):134-41. PubMed ID: 14972542
[TBL] [Abstract][Full Text] [Related]
9. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.
Kohno H; Inoue T; Tsuda F; Okamoto H; Akahane Y
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1825-31. PubMed ID: 8760433
[TBL] [Abstract][Full Text] [Related]
11. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen.
Ryu CJ; Gripon P; Park HR; Park SS; Kim YK; Guguen-Guillouzo C; Yoo OJ; Hong HJ
J Med Virol; 1997 Jun; 52(2):226-33. PubMed ID: 9179773
[TBL] [Abstract][Full Text] [Related]
12. Synthetic oligopeptides bearing a common or subtypic determinant of hepatitis B surface antigen.
Ohnuma H; Takai E; Machida A; Tsuda F; Okamoto H; Tanaka T; Naito M; Munekata E; Miki K; Miyakawa Y
J Immunol; 1990 Oct; 145(7):2265-71. PubMed ID: 1697880
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes.
Neurath AR; Kent SB; Strick N; Parker K; Courouce AM; Riottot MM; Petit MA; Budkowska A; Girard M; Pillot J
Mol Immunol; 1987 Sep; 24(9):975-80. PubMed ID: 3657811
[TBL] [Abstract][Full Text] [Related]
15. Allelic subtypic determinants of hepatitis B surface antigen (i and t) that are distinct from d/y or w/r.
Ohnuma H; Machida A; Okamoto H; Tsuda F; Sakamoto M; Tanaka T; Miyakawa Y; Mayumi M
J Virol; 1993 Feb; 67(2):927-32. PubMed ID: 7678309
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands.
Petit MA; Strick N; Dubanchet S; Capel F; Neurath AR
Mol Immunol; 1991; 28(4-5):517-21. PubMed ID: 1712075
[TBL] [Abstract][Full Text] [Related]
17. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).
Golsaz-Shirazi F; Amiri MM; Farid S; Bahadori M; Bohne F; Altstetter S; Wolff L; Kazemi T; Khoshnoodi J; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Protzer U; Shokri F
Antiviral Res; 2017 Aug; 144():153-163. PubMed ID: 28641998
[TBL] [Abstract][Full Text] [Related]
18. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen.
Ogata N; Ostberg L; Ehrlich PH; Wong DC; Miller RH; Purcell RH
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):3014-8. PubMed ID: 8464917
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays.
Kfoury Baz EM; Zheng J; Mazuruk K; Van Le A; Peterson DL
Transfus Med; 2001 Oct; 11(5):355-62. PubMed ID: 11696228
[TBL] [Abstract][Full Text] [Related]
20. Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies.
Jolivet-Reynaud C; Lésenéchal M; O'Donnell B; Becquart L; Foussadier A; Forge F; Battail-Poirot N; Lacoux X; Carman W; Jolivet M
J Med Virol; 2001 Oct; 65(2):241-9. PubMed ID: 11536229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
